Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,524 | 8,621 | 2,752 | 4,713 | 6,870 |
| Receivables | 914 | 1,078 | N/A | N/A | N/A |
| TOTAL | $8,533 | $9,868 | $2,943 | $4,991 | $7,099 |
| Non-Current Assets | |||||
| PPE Net | 368 | 386 | 384 | 31 | 95 |
| Intangibles | 65,195 | 65,195 | 65,195 | 65,195 | 65,195 |
| Other Non-Current Assets | 811 | 842 | 40 | 53,954 | 53,936 |
| TOTAL | $66,374 | $66,423 | $65,619 | $119,180 | $119,226 |
| Total Assets | $74,907 | $76,291 | $68,562 | $124,171 | $126,325 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,361 | 1,211 | 1,080 | 978 | 765 |
| Other current liabilities | 123 | 163 | 263 | 159 | 288 |
| TOTAL | $1,854 | $1,753 | $1,557 | $1,137 | $1,053 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 614 | 657 | 0 | 0 | 0 |
| TOTAL | $635 | $718 | $117 | $12,133 | $12,626 |
| Total Liabilities | $2,489 | $2,471 | $1,674 | $13,270 | $13,679 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,634 | 2,634 | 2,634 | 2,493 | 2,493 |
| Common Shares | 32 | 32 | 30 | 30 | 30 |
| Retained earnings | -185,635 | -184,120 | -187,091 | -142,805 | -140,940 |
| TOTAL | $72,418 | $73,820 | $66,888 | $110,901 | $112,646 |
| Total Liabilities And Equity | $74,907 | $76,291 | $68,562 | $124,171 | $126,325 |